Cargando…
Correction: Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063391/ https://www.ncbi.nlm.nih.gov/pubmed/31836583 http://dx.doi.org/10.1136/archdischild-2018-315051corr1 |
Ejemplares similares
-
Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial
por: Minocchieri, Stefan, et al.
Publicado: (2019) -
Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
por: Dixon, Barry, et al.
Publicado: (2021) -
Randomised controlled trial of nebulised gentamicin in children with bronchiectasis
por: Twiss, Jacob, et al.
Publicado: (2022) -
Treatment of asthma exacerbations with the human-powered nebuliser: a randomised parallel-group clinical trial
por: Hallberg, Christopher J, et al.
Publicado: (2014) -
Nebulised fentanyl for post-operative pain relief, a prospective double-blind controlled randomised clinical trial
por: Singh, Anil P, et al.
Publicado: (2013)